Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25935553.
- Also identified by DOI 10.1093/cid/civ353 and PMC identifier 4607736.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biofilms are microbial communities of surface-attached cells embedded in a self-produced extracellular matrix. They are of major medical significance because they decrease susceptibility to antimicrobial agents and enhance the spread of antimicrobial resistance. Biofilm-associated bacterial and fungal microorganisms have increasingly been recognized to play a role in multiple infectious diseases, particularly in their persistence and recurrence. More recently, biofilms have also been implicated in vaginal infections, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), particularly in the setting of treatment failure and recurrence. The purpose of this review is to discuss the impact of biofilms on the management and treatment of BV and recurrent VVC and highlight the need for additional research and development of novel therapeutics targeting pathogenic vaginal biofilms.
Medical subject headings
- Anti-Infective Agents
- Biofilms
- Candidiasis, Vulvovaginal
- Vaginosis, Bacterial